قاسم یزدان پناه - Dept. of Tissue Engineering, Faculty of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
مونا کاکاوند - Dept. of Tissue Engineering, Faculty of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
حسن نیک نژاد - ۲Dept .of Tissue Engineering and Nanomedicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Background and Objective: Amniotic membrane (AM) as a natural tissue has lots of unique features which make it a suitable candidate for vascular tissue engineering. The aim of this study was to evaluate blood compatibility of mesenchymal surface of the AM. Materials and Methods: In this study, the effect of mesenchymal surface of the AM on internal and external coagulation pathways, hemolysis and platelet activity was measured and the results were compared with heparin-coated ePTFE as a synthetic vessel substitute. In addition, platelet adhesion and their morphologic changes after being in contact with samples were analyzed by electron microscopy. Results: Prothrombin time (PT), activated partial thromboplastin time (aPTT), clotting time and hemolysis tests showed that the AM is hemocompatible. Additionally, mesenchymal surface of the AM induced platelet aggregation less than ePTFE while both similarly provoked secretion of P-selectin. Number of adhered platelets to mesenchymal surface of the AM was less than ePTFE. The platelets on the mesenchymal surface had round morphology whereas ePTFE exhibited dendritic shape platelets. Conclusion: Results of this study showed that the mesenchymal surface of the AM is hemocompatible which could be a proper candidate for vascular tissue engineering. ۱- Hoshi RA, Van Lith R, Jen MC, Allen JB, Lapidos KA, Ameer G. The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts. Biomaterials. ۲۰۱۳ ۳۴: ۳۰-۴۱. ۲- Zhang WJ, Liu W, Cui L, Cao Y. Tissue engineering of blood vessel. J Cell Mol Med. ۲۰۰۷ ۱۱: ۹۴۵-۵۷. ۳- Palumbo VD, Bruno A, Tomasello G, Damiano G, Lo Monte AI. Bioengineered vascular scaffolds: the state of the art. Int J Artif Organs. ۲۰۱۴ ۳۷: ۵۰۳-۱۲. ۴- Suma H. Arterial grafts in coronary bypass surgery. Ann Thorac Cardiovasc Surg. ۱۹۹۹ ۵: ۱۴۱-۵. ۵- Carnagey J, Hern-Anderson D, Ranieri J, Schmidt CE. Rapid endothelialization of photo fix natural biomaterial vascular grafts. J Biomed Mater Res B Appl Biomater. ۲۰۰۳ ۶۵: ۱۷۱-۹. ۶- Seifu DG, Purnama A, Mequanint K, Mantovani D. Small-diameter vascular tissue engineering. Nat Rev Cardiol. ۲۰۱۳ ۱۰: ۴۱۰-۲۱. ۷- Niknejad H, Deihim T, Ahmadiani A, Jorjani M, Peirovi H. Permanent expression of midbrain dopaminergic neurons traits in differentiated amniotic epithelial cells. Neurosci Lett. ۲۰۱۲ ۵۰۶: ۲۲-۷. ۸- Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. ۲۰۰۸ ۱۵: ۸۸-۹۹. ۹- Tehrani FA, Ahmadiani A, Niknejad H. The effects of preservation procedures on antibacterial property of amniotic membrane. Cryobiology. ۲۰۱۳ ۶۷: ۲۹۳-۸. ۱۰- Niknejad H, Khayat-Khoei M, Peirovi H. Inhibition of MMPs might increase anticancer properties of amniotic epithelial cells. Med Hypotheses. ۲۰۱۲ ۷۸: ۶۹۰-۱. ۱۱- Niknejad H, Yazdanpanah G. Anticancer effects of human amniotic membrane and its epithelial cells. Med Hypotheses. ۲۰۱۴ ۸۲: ۴۸۸-۹. ۱۲- Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. ۲۰۰۰ ۲۰: ۳۲۵-۳۴. ۱۳- Solomon A, Rosenblatt M, Monroy D, Ji Z, Pflugfelder SC, Tseng SC. Suppression of interleukin ۱alpha and interleukin ۱beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol. ۲۰۰۱ ۸۵: ۴۴۴-۹. ۱۴- Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. ۲۰۰۵ ۲۴: ۶۴۳-۵۳. ۱۵- Niknejad H, Deihim T, Solati-Hashjin M, Peirovi H. The effects of preservation procedures on amniotic membranechr('۳۹')s ability to serve as a substrate for cultivation of endothelial cells. Cryobiology. ۲۰۱۱ ۶۳: ۱۴۵-۵۱. ۱۶- Peirovi H, Rezvani N, Hajinasrollah M, Mohammadi SS, Niknejad H. Implantation of amniotic membrane as a vascular substitute in the external jugular vein of juvenile sheep. J Vasc Surg. ۲۰۱۲ ۵۶: ۱۰۹۸-۱۰۴. ۱۷- Niknejad H, Deihim T, Peirovi H, Abolghasemi H. Serum-free cryopreservation of human amniotic epithelial cells before and after isolation from their natural scaffold. Cryobiology. ۲۰۱۳ ۶۷: ۵۶-۶۳. ۱۸- Ko TM, Lin JC, Cooper SL. Surface characterization and platelet adhesion studies of plasma-sulphonated polyethylene. Biomaterials. ۱۹۹۳ ۱۴: ۶۵۷-۶۴. ۱۹- Goodman SL. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. J Biomed Mater Res. ۱۹۹۹ ۴۵: ۲۴۰-۵۰. ۲۰- Motlagh D, Allen J, Hoshi R, Yang J, Lui K, Ameer G. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J Biomed Mater Res A. ۲۰۰۷ ۸۲: ۹۰۷-۱۶. ۲۱- Niknejad H, Khayat-Khoei M, Peirovi H, Abolghasemi H. Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy. Cytotherapy. ۲۰۱۴ ۱۶: ۳۳-۴۰. ۲۲- Niknejad H, Yazdanpanah G, Mirmasoumi M, Abolghasemi H, Peirovi H, Ahmadiani A. Inhibition of HSP۹۰ could be possible mechanism for anti-cancer property of amniotic membrane. Med Hypotheses. ۲۰۱۳ ۸۱: ۸۶۲-۵. ۲۳- Niknejed H, Yazdanpanah G, Khayat-khoei M. In vitro evaluation of the effects of amniotic membrane on viability and proliferation of cancer cells. J Zanjan Unive Med Sci. ۲۰۱۳ ۲۱: ۱۳-۲۱. ۲۴- Lin WC, Liu TY, Yang MC. Hemocompatibility of polyacrylonitrile dialysis membrane immobilized with chitosan and heparin conjugate. Biomaterials. ۲۰۰۴ ۲۵: ۱۹۴۷-۵۷. ۲۵- Wennberg A, Hensten-Pettersen A. Sensitivity of erythrocytes from various species to in vitro hemolyzation. J Biomed Mater Res. ۱۹۸۱ ۱۵: ۴۳۳-۵. ۲۶- Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. ۲۰۰۰ ۱۹: ۳۴۸-۵۲. ۲۷- Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG۲/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem. ۱۹۹۲ ۲۶۷: ۸۵۴۴-۵۷. ۲۸- Kuriu Y, Yamagishi H, Otsuji E, et al. Regeneration of peritoneum using amniotic membrane to prevent postoperative adhesions. Hepatogastroenterology. ۲۰۰۹ ۵۶: ۱۰۶۴-۸. ۲۹- Zaga-Clavellina V, Flores-Espinosa P, Pineda-Torres M, et al. Tissue-specific IL-۱۰ secretion profile from term human fetal membranes stimulated with pathogenic microorganisms associated with preterm labor in a two-compartment tissue culture system. J Mater Fet Neo Med. ۲۰۱۴ ۲۷: ۱۳۲۰-۷. ۳۰- Choi G, Schultz MJ, Levi M, van der Poll T. The relationship between inflammation and the coagulation system. Swiss Med Wkly. ۲۰۰۶ ۱۳۶: ۱۳۹-۴۴. ۳۱- Shao C, Sima J, Zhang SX, et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci. ۲۰۰۴ ۴۵: ۱۷۵۸-۶۲. ۳۲- Lee Y-M, Lee J-J, Shen M-Y, Hsiao G, Sheu J-R. Inhibitory mechanisms of activated matrix metalloproteinase-۹ on platelet activation. Eur J Pharmacol. ۲۰۰۶ ۵۳۷: ۵۲-۸. ۳۳- Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. ۲۰۰۷ ۷۷: ۵۷۷-۸۸. ۳۴- Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. ۲۰۰۴ ۲۲: ۳۷۷-۸۴. ۳۵- Niknejad H, Paeini-Vayghan G, Tehrani FA, Khayat-Khoei M, Peirovi H. Side dependent effects of the human amnion on angiogenesis. Placenta. ۲۰۱۳ ۳۴: ۳۴۰-۵. ۳۶- Mitchell SL, Niklason LE. Requirements for growing tissue-engineered vascular grafts. Cardiovasc Pathol. ۲۰۰۳ ۱۲: ۵۹-۶۴.

Keywords: Amniotic membrane, Hemocompatibility, Vascular tissue engineering, Stem cells, ePTFE